Cargando…
Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial()()
BACKGROUND: Seborrheic dermatitis (SD) is a chronic dermatitis with periods of remission and relapse that requires long-term treatment. OBJECTIVE: We compared the efficacy and safety of treatment with sertaconazole with standard corticosteroid medications in adults with facial SD. METHODS: In this d...
Autores principales: | Balighi, K., Ghodsi, S.Z., Daneshpazhooh, M., Ghale-Baghi, S., Nasimi, M., Azizpour, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440452/ https://www.ncbi.nlm.nih.gov/pubmed/28560305 http://dx.doi.org/10.1016/j.ijwd.2016.11.008 |
Ejemplares similares
-
A Meta-Analysis on the Effectiveness of Sertaconazole 2% Cream Compared with Other Topical Therapies for Seborrheic Dermatitis
por: Georgescu, Simona Roxana, et al.
Publicado: (2022) -
The Efficacy and Safety of Sertaconazole Cream (2 %) in Diaper Dermatitis Candidiasis
por: Bonifaz, Alexandro, et al.
Publicado: (2013) -
Treatment of Facial Seborrheic Dermatitis with Pimecrolimus Cream 1%: An Open-Label Clinical Study in Korean Patients
por: Kim, Byung-Soo, et al.
Publicado: (2007) -
Comparative Assessment of the Efficacy and Safety of Sertaconazole (2%) Cream Versus Terbinafine Cream (1%) Versus Luliconazole (1%) Cream In Patients with Dermatophytoses: A Pilot Study
por: Jerajani, HR, et al.
Publicado: (2013) -
Novel Non-Steroidal Facial Cream Demonstrates Antifungal and Anti-Inflammatory Properties in Ex Vivo Model for Seborrheic Dermatitis
por: Granger, Corinne, et al.
Publicado: (2019)